furapromide

structure; RN given refers to parent cpd without isomeric designation

Also Known As:

F-30066; cis-beta-(5-nitro-2-furyl)-N-isopropylacrylamide; furapromide, (E)-isomer; furapromidum; N-isopropyl-3-(5-nitro-2-furyl)acrylamide

Networked: 6 relevant articles (0 outcomes, 1 trials/studies)

1.	Schistosomiasis japonica 01/01/2010 - "Activity of furapromidum against Schistosoma japonicum was reported in the early 1960s, and this drug became the first non-antimonial used in clinical treatment of schistosomiasis japonica. " 06/01/1981 - "[Clinical studies on treatment of schistosomiasis japonica with a combination of pyquiton and furapromide]." 02/01/1981 - "[Coadministration of pyquiton and furapromidum in the treatment of experimental schistosomiasis japonica (author's transl)]." 03/01/1977 - "Combined oral furapromidum and rectal dipterex in schistosomiasis japonica."
2.	Schistosomiasis (Bilharziasis) 12/01/1980 - "[Comparative study of two kinds of enteric-coated furapromidum with rectal dipterex in treatment for schistosomiasis (author's transl)]."
3.	Clonorchiasis 10/01/1965 - "F30066 (Furapromidum) in the treatment of clonorchiasis sinensis."